Cyclo(RGDfC) is primarily used in biomedical research and therapeutic development due to its ability to inhibit integrin-mediated cell adhesion. It is commonly applied in studies targeting angiogenesis, cancer metastasis, and tissue regeneration. The compound is particularly valuable in designing drug delivery systems, as it can enhance the targeting of therapeutic agents to specific cells or tissues. Additionally, it is utilized in developing imaging probes for diagnostic purposes, helping to visualize tumor growth and vascularization. Its role in modulating cellular interactions makes it a key tool in understanding and treating diseases involving abnormal cell adhesion and migration.